Findings from a pilot study offer new clues for identifying which preterm infants in neonatal intensive care units may be at risk for allergic sensitisation and the development of asthma.
‘This could lead to the development of therapeutic interventions during a critical window of immune development to reduce the risk’, write the researchers.
Their work has just been published in Nature’s Scientific Reports: The impact of maternal asthma on the preterm infants’ gut metabolome and microbiome (MAP study). Find the details here.
FLRF is a proud contributor to this foundational research, through the MOMI Seeds grant program for early stage, multidisciplinary research offered by the Larsson-Rosenquist Foundation Mother-Milk-Infant Center of Research Excellence (MOMI CORE) at the University of California San Diego.
Interested to discover more about other projects sprouting from MOMI Seeds and MOMI CORE? Please subscribe to our newsletter.